Survival and autoimmune risks post-thymectomy

The benefits of thymectomy outweigh potential risks for patients with MG or patients with thymic malignancies. Incidental thymectomy should be avoided. This call for reevaluation of thymectomy especially for non-neoplastic causes.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-03-13
DOI
https://doi.org/10.3389/fimmu.2025.1504496
Citations
10
Primary Topic
Myasthenia Gravis and Thymoma
Type
article
Field-Weighted Citation Impact
13.89
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Survival and autoimmune risks post-thymectomy

Mohamed Khateb, Shahar Shelly, Dvir Aran, Irina Tsirkin et al.
10 citations
Frontiers in Immunology
Myasthenia Gravis and Thymoma
13.89
article

Survival and autoimmune risks post-thymectomy

Mohamed Khateb, Shahar Shelly, Dvir Aran, Irina Tsirkin, Amit Kaz
article en
10 citations

Abstract

The benefits of thymectomy outweigh potential risks for patients with MG or patients with thymic malignancies. Incidental thymectomy should be avoided. This call for reevaluation of thymectomy especially for non-neoplastic causes.

Frontiers in ImmunologyVol. 16
Technion – Israel Institute of Technology (IL), Assuta Medical Center (IL), Rambam Health Care Campus (IL), Mayo Clinic in Arizona (US)
Good health and well-being
Openalex Percentile: Top 1%
Myasthenia Gravis and Thymoma
13.89
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.